Matthew W. Emmens
Overview
Matthew W. Emmens received an average of $14M in total compensation, including $941K in salary, at Vertex Pharmaceuticals from 2009 to 2012.
Source: SEC filings on April 4, 2013 and April 10, 2012.
Related executives
We found 19 more executives who work or worked at Vertex Pharmaceuticals.
Reshma Kewalramani
Vertex Pharmaceuticals
Chief Executive Officer
Jeffrey Leiden
Vertex Pharmaceuticals
Chairman
Stuart Arbuckle
Vertex Pharmaceuticals
Chief Operating Officer
Nia Tatsis
Vertex Pharmaceuticals
EVP & Chief Regulatory and Quality Officer
Charles Wagner
Vertex Pharmaceuticals
Chief Financial Officer
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Patient Officer
Paul Silva
Vertex Pharmaceuticals
SVP & Corporate Controller
Ian Smith
Vertex Pharmaceuticals